Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 2
Results: 14
Circulating tumor cell count: A reliable biomarker for treatment selection in metastatic breast cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 265, doi. 10.1111/1759-7714.14269
- By:
- Publication type:
- Article
Inhibitory effects of icotinib combined with antiangiogenic drugs in human non‐small cell lung cancer xenograft models are better than single target drugs.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 257, doi. 10.1111/1759-7714.14261
- By:
- Publication type:
- Article
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 228, doi. 10.1111/1759-7714.14252
- By:
- Publication type:
- Article
Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 247, doi. 10.1111/1759-7714.14260
- By:
- Publication type:
- Article
Risk factors for in‐hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 236, doi. 10.1111/1759-7714.14254
- By:
- Publication type:
- Article
Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 219, doi. 10.1111/1759-7714.14248
- By:
- Publication type:
- Article
Trend of lung cancer surgery, hospital selection, and survival between 2005 and 2016 in South Korea.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 210, doi. 10.1111/1759-7714.14247
- By:
- Publication type:
- Article
Utility of mass spectrometry and artificial intelligence for differentiating primary lung adenocarcinoma and colorectal metastatic pulmonary tumor.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 202, doi. 10.1111/1759-7714.14246
- By:
- Publication type:
- Article
Icaritin alleviates docetaxel‐induced skin injury by suppressing reactive oxygen species via estrogen receptors.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 190, doi. 10.1111/1759-7714.14245
- By:
- Publication type:
- Article
Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 182, doi. 10.1111/1759-7714.14237
- By:
- Publication type:
- Article
Impact of docetaxel plus ramucirumab in a second‐line setting after chemoimmunotherapy in patients with non‐small‐cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 173, doi. 10.1111/1759-7714.14236
- By:
- Publication type:
- Article
CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR‐433‐3p in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 162, doi. 10.1111/1759-7714.14235
- By:
- Publication type:
- Article
Robot‐assisted thoracic surgery versus video‐assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta‐analysis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 151, doi. 10.1111/1759-7714.14234
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 149, doi. 10.1111/1759-7714.14016
- Publication type:
- Article